参考文献/References:
[1] MEGAW R,AGARWAL P K.Posner-Schlossman syndrome[J].Surv Ophthalmol,2017,62(3):277-285.
[2] MARUYAMA K,MARUYAMA Y,SUGITA S,MORI K,YOKOYAMA Y,SANUKI-KUNIMATSU S,et al.Characteristics of cases needing advanced treatment for intractable Posner-Schlossman syndrome[J].BMC Ophthalmol,2017,17(1):45-51.
[3] OHIRA S,INOUE T,IWAO K,TAKAHASHI E,TANIHARA H.Factors influencing aqueous proinflammatory cytokines and growth factors in uveitic glaucoma[J].PLoS One,2016,11(1):e0147080.
[4] HONG Y,WANG M,WU L.In vivo confocal microscopy of Posner-Schlossman syndrome:comparison with herpes simplex keratitis,HLA-B27 anterior uveitis and acute attack of primary angle closure[J].Sci Rep,2017,7(1):9832-9837.
[5] 张旭东.实用眼科学[M].北京:科学出版社,2015:206-207.
ZHANG X D.Practical Ophthalmology[M].Beijing:Science Press,2015:206-207.
[6] ACCORINTI M,GILARDI M,PIRRAGLIA M P,AMORELLI G M,NARDELLA C,ABICCA I,et al.Erratum to:cytomegalovirus anterior uveitis:long-term follow-up of immunocompetent patients[J].Graefes Arch Clin Exp Ophthalmol,2014,252(11):1817-1824.
[7] 许欢,翟如仪,孔祥梅,王朱健,王晓蕾.青光眼睫状体炎综合征患者房水病毒情况分析[J].中国眼耳鼻喉科杂志,2018,18(1):18-21.
XU H,ZHAI R Y,KONG X M,WANG Z J,WANG X L.Analysis of aqueous viruses in patients with glaucomatocyclitis syndrome[J].Chin J Ophthalmol Otorhinol,2018,18 (1):18-21.
[8] 王晓蕾,王朱健,汤荔,曹文俊,孙兴怀.青光眼睫状体炎综合征房水CMV IgG抗体白蛋白校正比值的研究[J].中华眼科杂志,2017,53(2):104-108.
WANG X L,WANG Z J,TANG L,CAO W J,SUN X H.Study on the correction ratio of CMV IgG antibody to albumin in aqueous humor of glaucomyelitis syndrome[J].Chin J Ophthalmol,2017,53 (2):104-108.
[9] CHAN N S,CHEE S P,CASPERS L,BDOAGHI B.Review for disease of the year:clinic of cytomegalovirus-induced anterior uveitis[J].Ocul Immunol Inflamm,2018,26(7):1135-1142.
[10] JIANG J H,ZHANG S D,DAI M L,YANG J Y,XIE Y Q,HU C,et al.Posner-Schlossman syndrome in Wenzhou,China:a retrospective review study[J].Br J Ophthalmol,2017,101(12):1638-1642.
[11] SOBOLEWSKA B,DEUTER C,DOYCHEVA D,ZIERHUT M.Long-term oral therapy with valganciclovir in patients with Posner-Schlossman syndrome[J].Graefes Arch Clin Exp Ophthalmol,2014,252(1):117-124.
[12] POHLMANN D.Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs’ Uveitis[J].PLoS One,2018,13(6):e0199301.
[13] ZHAO J,CHEN W,HUANG X,PENG S,ZHU T,DENG Z,et al.Serum Th1 and Th17 related cytokines and autoantibodies in patients with Posner-Schlossman syndrome[J].PLoS One,2017,12(4):e0175519.
[14] SU C C,HU F R,WANG T H,HUANG J Y,YEH P T,LIN C P,et al.Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy[J].Am J Ophthalmol,2014,158(5):1024-1031.
[15] ZHAO J,ZHU T,CHEN W,FAN B J,HE L,YANG B,et al.Human leukocyte antigens-B and-C loci associated with posner-schlossman syndrome in a Southern Chines population[J].PLoS One,2015,10(7):e0132179.
[16] HEDAYATFAR A,CHEE S P.Posner-Schlossman syndrome associated with cytomegalovirus infection:a case series from a non-endemic area[J].Int Ophthalmol,2014,34(5):1123-1129.